NCBI PubMed Central
open access
Innovative approaches in the treatment of hematologic malignancies: the role of CRISPR-engineered microbiomes along the gut-immune axis in immunotherapy development.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives#120190
- Exploring the Molecular Mechanism Based on KIT Mutation#895584
- Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma#870035
- Delivery, use and therapeutic applications of the crispr-cas systems and … — The Broad Institute, Inc. (US20250381297A1)#607482
- Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy#665380
Record · ID 275517
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive